Precision Breast Cancer Screening with a Polygenic Risk Score

Tõnis Tasa, Mikk Puustusmaa, Neeme Tõnisson, Berit Kolk, Peeter Padrik
doi: https://doi.org/10.1101/2020.08.17.20176263

Article Information

doi 
https://doi.org/10.1101/2020.08.17.20176263
History 
  • August 19, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Tõnis Tasa1,*,
  2. Mikk Puustusmaa1,
  3. Neeme Tõnisson1,2,4,
  4. Berit Kolk1 and
  5. Peeter Padrik1,3,5
  1. 1Antegenes, Tartu, Estonia
  2. 2Institute of Genomics, University of Tartu, Tartu, Estonia
  3. 3Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
  4. 4Center of Genetics, Tartu University Hospital, Tartu, Estonia
  5. 5Clinic of Hematology and Oncology, Tartu University Hospital, Tartu, Estonia
  1. ↵*Corresponding Author: Tõnis Tasa Email address: tonis.tasa{at}antegenes.com
Back to top
Posted August 19, 2020.
Download PDF
Data/Code
Email
Precision Breast Cancer Screening with a Polygenic Risk Score
Tõnis Tasa, Mikk Puustusmaa, Neeme Tõnisson, Berit Kolk, Peeter Padrik
medRxiv 2020.08.17.20176263; doi: https://doi.org/10.1101/2020.08.17.20176263
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area